RIPK3 ubiquitination is enhanced with the phospho-mimetic S9D parkin, providing evidence that parkin phosphorylation at S9 has a protective, tumor suppressor effect against necroptosis and tumor formation [188]. Here, PRKN is linked to neoplasm.